The first-in-human phase 1/2 study of TSN1611, a highly selective KRAS G12D inhibitor, in patients with advanced solid tumors. Seizure-related homolog 6 (SEZ6) expression and ctDNA methylation ...
A team of medical researchers at the National Institute on Alcohol Abuse and Alcoholism has identified some of the genes and proteins associated with alcohol use disorders. In their project reported ...